- High gross margin of 100.0%
- Low bankruptcy risk (Altman Z-Score: 6.66)
- Lower volatility than the market (beta 0.34)
Lexaria Bioscience Corp. stock price fell more than -5.22% Tuesday closing at $0.530
(Updated on Jul 07, 2026)
The Lexaria Bioscience Corp. stock price fell by -5.22% on the last day (Tuesday, 7th Jul 2026) from $0.560 to $0.530. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 9.22% from a day low at $0.530 to a day high of $0.579. The price has fallen in 7 of the last 10 days and is down by -9.01% for this period. Volume has increased on the last day by 5 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 17 thousand shares were bought and sold for approximately $8.97 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.01% during the next 3 months and, with a 90% probability hold a price between $0.271 and $0.376 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
LEXX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 0.0566%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lexaria Bioscience Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.554 and $0.596. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Lexaria Bioscience Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Lexaria Bioscience Corp. stock
Lexaria Bioscience Corp. finds support from accumulated volume at $0.530 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0489 between high and low, or 9.22%. For the last week, the stock has had daily average volatility of 6.24%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LEXX) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect Lexaria Bioscience Corp. to open at $0.546, and during the day (based on 14 day Average True Range), to move between $0.507 and $0.553, which gives a possible trading interval of +/-$0.0457 (+/-9.00%) up or down from last closing price. If Lexaria Bioscience Corp. takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.530 (0.06%) than the resistance at $0.577 (8.77%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Lexaria Bioscience Corp. will release earnings BMO on Monday, July 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0600. We will update the financials statements for Lexaria Bioscience Corp., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.77% in the first trading day after earnings release.
Is Lexaria Bioscience Corp. stock A Buy?
Lexaria Bioscience Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-4.385
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 8, 2026 - $0.546 ( 3.05%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LEXX Performance
Trading levels for LEXX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.595 | 12.27% |
| R2 | 0.577 | 8.75% |
| R1 | 0.565 | 6.57% |
| Price | 0.530 | |
| S1 | 0.528 | -0.474% |
| S2 | 0.516 | -2.65% |
| S3 | 0.498 | -6.17% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.659 | 24.27% |
| R2 | 0.610 | 14.99% |
| R1 | 0.577 | 8.77% |
| Price | 0.530 | |
| S1 | 0.530 | -0.0566% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Lexaria Bioscience Corp. Stock.
Buy LEXX